Vusion


Vusion buys Pricer: who’s the pricey one?

17/11/26 -"Pricer may be the name of the target, but Vusion looks even more like the pricey one. By offering less than 5x EBITDA 2027e for its closest competitor while trading at 7x itself, Vusion has ..."

Pages
62
Language
English
Published on
17/11/26
You may also be interested by these reports :
17/11/26
Pricer may be the name of the target, but Vusion looks even more like the pricey one. By offering less than 5x EBITDA 2027e for its closest ...

13/11/26
Shelly Q3 results were mixed with profit margins taking a hit mostly due to growth investments but cash conversion again improved. The outlook was ...

10/11/26
Shelly’s Q3 results were mixed with profit margins taking a hit mostly due to growth investments, but cash conversion again improved. The outlook was ...

02/11/26
Over the week to 30-10-2026, European equities had a positive week with the Stoxx600 gaining 1.7%, despite a difficult Friday (-0.4%). Corporate ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO